Mitchell Gold Alpine Immune Sciences, Inc. (ALPN) insider trading activity

Mitchell Gold is Executive Chairman and CEO of ALPINE IMMUNE SCIENCES, INC.. Currently has a direct ownership of 0 shares of ALPN, which is worth approximately $0. The most recent transaction as insider was on May 20, 2024, when has been sold 109,245 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

MITCHELL GOLD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2024	SELL Sale (or disposition) back to the issuer	-	109,245 Reduced 100.0%	0 Common Stock
May 08 2024	BUY Exercise of conversion of derivative security	$99,999 $7.55 p/Share	13,245 Added 10.81%	109,245 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	96,000 Added 50.0%	96,000 Common Stock
Dec 28 2023	SELL Open market or private sale	$20,360 $20.04 p/Share	1,016 Reduced 100.0%	0 Common Stock
Dec 28 2023	BUY Exercise of conversion of derivative security	$660 $0.65 p/Share	1,016 Added 50.0%	1,016 Common Stock
Dec 27 2023	SELL Open market or private sale	$592,642 $20.04 p/Share	29,573 Reduced 100.0%	0 Common Stock
Dec 27 2023	BUY Exercise of conversion of derivative security	$19,222 $0.65 p/Share	29,573 Added 50.0%	29,573 Common Stock
Dec 26 2023	SELL Open market or private sale	$495,106 $20.22 p/Share	24,486 Reduced 100.0%	0 Common Stock
Dec 26 2023	BUY Exercise of conversion of derivative security	$13,467 $0.55 p/Share	24,486 Added 50.0%	24,486 Common Stock
Dec 22 2023	SELL Open market or private sale	$772,764 $20.43 p/Share	37,825 Reduced 100.0%	0 Common Stock
Dec 22 2023	BUY Exercise of conversion of derivative security	$17,021 $0.45 p/Share	37,825 Added 50.0%	37,825 Common Stock
Dec 19 2023	SELL Open market or private sale	$48,064 $20.01 p/Share	2,402 Reduced 100.0%	0 Common Stock
Dec 19 2023	BUY Exercise of conversion of derivative security	$1,080 $0.45 p/Share	2,402 Added 50.0%	2,402 Common Stock
Dec 12 2023	SELL Open market or private sale	$711,211 $17.32 p/Share	41,063 Reduced 100.0%	0 Common Stock
Dec 12 2023	BUY Exercise of conversion of derivative security	$3,875 $0.45 p/Share	8,613 Added 50.0%	8,613 Common Stock
Dec 11 2023	SELL Open market or private sale	$1,188,696 $17.26 p/Share	68,870 Reduced 67.97%	32,450 Common Stock
Dec 08 2023	SELL Open market or private sale	$137,784 $17.08 p/Share	8,067 Reduced 7.37%	101,320 Common Stock
Sep 17 2021	SELL Open market or private sale	$453,073 $10.01 p/Share	45,262 Reduced 29.27%	109,387 Common Stock
Sep 16 2021	SELL Open market or private sale	$67,680 $10.0 p/Share	6,768 Reduced 4.19%	154,649 Common Stock
Sep 15 2021	SELL Open market or private sale	$34,840 $10.0 p/Share	3,484 Reduced 2.11%	161,417 Common Stock
Jun 28 2021	SELL Open market or private sale	$34,790 $10.0 p/Share	3,479 Reduced 2.07%	164,901 Common Stock
Jun 25 2021	SELL Open market or private sale	$94,825 $10.01 p/Share	9,473 Reduced 5.33%	168,380 Common Stock
May 20 2021	SELL Open market or private sale	$18,315 $15.0 p/Share	1,221 Reduced 0.68%	177,853 Common Stock
May 19 2021	SELL Open market or private sale	$766,004 $15.03 p/Share	50,965 Reduced 22.15%	179,074 Common Stock
May 13 2021	SELL Open market or private sale	$115,200 $11.52 p/Share	10,000 Reduced 4.17%	230,039 Common Stock

Mitchell Gold

Executive Chairman and CEO

Seattle, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALPN shares.

Notify only if

Value

Insider Trading

Get notified when an Alpine Immune Sciences, Inc. insider buys or sells ALPN shares.

Notify only if

Operation

Value

Type

News

Receive news related to ALPINE IMMUNE SCIENCES, INC.

Track Activities on ALPN

Account